产品资料

CFPAC-1细胞

如果您对该产品感兴趣的话,可以
产品名称: CFPAC-1细胞
产品型号: CFPAC-1
产品展商: HZbscience
产品文档: 无相关文档

简单介绍

CFPAC-1细胞应如何避免细胞污染,细胞污染的种类可分成**、酵母菌、霉菌、病毒和霉浆菌。主要的污染原因为无菌操作技术不当、操作室环境不佳、污染之血清和污染之细胞等。严格之无菌操作技术、清洁的环境、与品质良好之细胞来源和培养基配制是减低污染之*好方法。CFPAC-1细胞何时须更换培养基?视细胞生长密度而定,或遵照细胞株基本数据上之更换时间,按时更换培养基即可。


CFPAC-1细胞  的详细介绍

CFPAC-1细胞

年限: 26 years

细胞形态: 上皮样

是否是肿瘤细胞: 1

物种来源: 人

ATCC Number: CRL-1918™

相关**: 其他**

生长状态: 贴壁生长

数量: 大量

器官来源: 胰腺

运输方式: 冻存运输

Designations: CFPAC-1

Depositors: RA Schoumacher

CFPAC-1细胞Biosafety Level: 1

Shipped: frozen

Medium & Serum: See Propagation

Growth Properties: adherent

Organism: Homo sapiens

Morphology: epithelial


Source: Organ: pancreas

Disease: ductal adenocarcinoma; cystic fibrosis

Derived from metastatic site: liver metastasis

Cellular Products: carcinoembryonic antigen (CEA), 9 ng/ml; pancreatic oncofetal antigen (POA), 28 ng/ml; adenocarcinoma associated antigen (ACAA), 5000 ng/ml; CA 19-9 antigen, 12000 units/ml; epithelial keratins

Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

Applications: CFPAC-1细胞transfection host

Tumorigenic: Yes

Antigen Expression: CA19-9 antigen, 12000 units/ml

DNA Profile (STR): Amelogenin: X,Y

CSF1PO: 10

D13S317: 12

D16S539: 9,11

D5S818: 10,11

D7S820: 8,10

THO1: 8

TPOX: 8

vWA: 17

Cytogenetic Analysis: hyperdiploid; modal number = 73; range = 65 to 75; several translocations were evident; two to three apparently normal copies of number 7 (to which the cystic fibrosis gene has been mapped) were present in every metaphase examined

Age: 26 years

Gender: male

Ethnicity: Caucasian

Comments: This line was derived from a ductal adenocarcinoma (liver metastasis) from a patient with cystic fibrosis.

The cells exhibit ion transport activities consistent with cystic fibrosis and express the product of the CF gene (cystic fibrosis transmembrane regulator, CFTR).

CFPAC-1细胞CFPAC-1 cells show no effect of cAMP agonists, adenyl cyclase stimulators or phosphodiesterase inhibitors on Cl- flux, but do respond to Ca++ ionophores with increase Cl- efflux.

The cells have the most common form of the CF mutation, deletion of three nucleotides resulting in the absence of phenylalanine at position 508.

CFPAC-1 cells have epithelial morphology and polarization with apical microvilli, tight junctions and gap junctions.

Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Iscove's Modified Dulbecco's Medium, Catalog No. 30-2005. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.

Atmosphere: air, 95%; carbon dioxide (CO2), 5%

Temperature: 37.0°C

Subculturing: Protocol:

Remove and discard culture medium.

Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.

Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).

Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37�C to facilitate dispersal.

Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.

Add appropriate aliquots of the cell suspension to new culture vessels.

Incubate cultures at 37�C.


Subcultivation Ratio: CFPAC-1细胞A subcultivation ratio of 1:3 to 1:10 is recommended

Medium Renewal: Every 2 to 3 days

Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO

Storage temperature: liquid nitrogen vapor phase

Doubling Time: 32 hrs

References: 1785: Schoumacher RA, et al. A cystic fibrosis pancreatic adenocarcinoma cell line. Proc. Natl. Acad. Sci. USA 87: 4012-4016, 1990. PubMed: 1692630

22227: McIntosh JC, et al. Pancreatic adenocarcinoma in a patient with cystic fibrosis. Am. J. Med. 85: 592, 1988. PubMed: 3177424

沪公网安备 31011702004356号